Novel Approaches to Epigenetic Therapies: From Drug Combinations to Epigenetic Editing
Cancer development involves both genetic and epigenetic alterations. Aberrant epigenetic modifications are reversible, allowing excellent opportunities for therapeutic intervention. Nowadays, several epigenetic drugs are used worldwide to treat, e.g., myelodysplastic syndromes and leukemias. However...
Main Authors: | Aleksandra Majchrzak-Celińska, Anna Warych, Mikołaj Szoszkiewicz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/12/2/208 |
Similar Items
-
Epigenetic therapy for ovarian cancer: promise and progress
by: Sara Moufarrij, et al.
Published: (2019-01-01) -
Epigenetics in cancer therapy and nanomedicine
by: Annalisa Roberti, et al.
Published: (2019-05-01) -
Statins Do Not Directly Inhibit the Activity of Major Epigenetic Modifying Enzymes
by: Stephanie Bridgeman, et al.
Published: (2019-04-01) -
Epigenetics and Colorectal Cancer Pathogenesis
by: Kebin Liu, et al.
Published: (2013-06-01) -
Epigenetic regulation of prostate cancer
by: Ruixin Wang, et al.
Published: (2020-12-01)